Fear of Movement and Catastrophizing in Participants with Temporomandibular Disorders

Aims: To assess differences in catastrophizing and kinesiophobia in relation to areas of pain and somatic symptoms among participants with temporomandibular disorders (TMDs) and controls. Methods: In total, 401 participants (333 women, 68 men, mean age: 45.8 years) in the TMJ Impact Project were examined in accordance with the Diagnostic Criteria for TMD, including clinical examination (Axis I) and psychosocial assessment (Axis II) augmented with imaging of the temporomandibular joint (TMJ). Of these, 218 participants had a painful TMD pain diagnosis, 63 had a nonpainful TMD diagnosis, and 111 had no TMD. Nine participants had missing data. Participants completed the Pain Catastrophizing Scale, Tampa Scale for Kinesiophobia, Areas of Pain figure, and the Patient Health Questionnaire-15 for assessing somatic symptoms. Results: Compared to controls, participants with TMD pain showed higher levels of catastrophizing (P = .017), kinesiophobia (P < .001), areas of pain (P < .001), and somatic symptoms (P < .001). Participants with nonpainful TMD showed a higher level of kinesiophobia (P < .001) than controls. There was a positive correlation between catastrophizing and kinesiophobia for participants with TMD pain (r = 0.33, P < .001) and nonpainful TMD (r = 0.42, P < .001). Discussion: The results suggest more fear of movement, as well as an association between catastrophizing and fear of movement, in participants with TMD pain and in participants with nonpainful TMD compared to controls. Assessment and management of fear of movement as well as catastrophizing may be useful as part of individualized treatment strategies for patients with TMD.

catastrophization; facial pain; kinesiophobia; somatic symptoms; temporomandibular joint disorders

1. Dworkin S, LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examina-tions and specifications, critique. J Craniomandib Disord 1992;6:301–355.

2. National Institute of Dental and Craniofacial Research. Facial pain. Updated July 2018. https://www.nidcr.nih.gov/research/data-statistics/facial-pain. Accessed 10 January 2022.

3. Lövgren A, Häggman-Henrikson B, Visscher CM, Lobbezoo F, Marklund S, Wänman A. Temporomandibular pain and jaw dysfunction at different ages covering the lifespan – a population based study. Eur J Pain 2016;20:532–540.

4. National Institute of Dental and Craniofacial Research. Prevalence of TMJD and its signs and symptoms. Updated July 2018. https://www.nidcr.nih.gov/research/data-statistics/facial-pain/prevalence. Accessed 10 January 2022.

5. Häggman-Henrikson B, Liv P, Ilgunas A, et al. Increasing gender differences in the prevalence and chronification of orofacial pain in the population. Pain 2020;161:1768–1775.

6. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

7. Sullivan MJL, Lynch ME, Clark AJ. Dimensions of cata-strophic thinking associated with pain experience and disability in patients with neuropathic pain conditions. Pain 2005;113:310–315.

8. Wertli MM, Eugster R, Held U, Steurer J, Kofmehl R, Weiser S. Catastrophizing-a prognostic factor for outcome in patients with low back pain: A systematic review. Spine J 2014;14:2639–2657.

9. Pavlin DJ, Sullivan MJ, Freund PR, Roesen K. Catastrophizing: A risk factor for postsurgical pain. Clin J Pain 2005;21:83–90.

10. Vlaeyen JWS, Kole-Snijders AMJ, Boeren RGB, van Eek H. Fear of movement/(re)injury in chronic low back pain and its relation to behavioral performance. Pain 1995;62:363–372.

11. Vlaeyen JWS, Linton SJ. Fear-avoidance model of chronic musculoskeletal pain: 12 years on. Pain 2012;153:1144–1147.

12. Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain 2000;85:317–332.

13. Visscher CM, Ohrbach R, van Wijk AJ, Wilkosz M, Naeije M. The Tampa Scale for Kinesiophobia for Temporomandibular Disorders (TSK-TMD). Pain 2010;150:492–500.

14. Gil-Martínez A, Grande-Alonso M, La Touche R, Lara-Lara M, López-López A, Fernández-Carnero J. Psychosocial and somatosensory factors in women with chronic migraine and painful temporomandibular disorders. Pain Res Manag 2016;2016:3945673.

15. Velly AM, Look JO, Carlson C, et al. The effect of catastrophizing and depression on chronic pain–a prospective cohort study of temporomandibular muscle and joint pain disorders. Pain 2011;152:2377–2383.

16. Wheeler CHB, Williams ACC, Morley SJ. Meta-analysis of the psychometric properties of the Pain Catastrophizing Scale and associations with participant characteristics. Pain 2019;160:1946–1953.

17. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med 2001;16:266–275.

18. Velly A, List T, Lobbezoo F. Comorbid pain and psychological conditions in patients with orofacial pain. In: Sessle BJ (ed). Orofacial Pain: Recent Advances in Assessment, Management, and Understanding of Mechanisms. Washington, DC: IASP, 2014:53–73.

19. Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: The OPPERA prospective cohort study. J Pain 2013;14(suppl 12):T75–T90.

20. Schiffman EL, Ahmad M, Hollender L, et al. Longitudinal stability of common TMJ structural disorders. J Dent Res 2017;96:270–276.

21. Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess 1995;7:524–532.

22. Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O’Neill E. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med 1997;20:589–605.

23. Darnall BD, Sturgeon JA, Cook KF, et al. Development and validation of a daily pain catastrophizing scale. J Pain 2017;18:1139–1149.

24. Rhon DI, Lentz TA, George SZ. Unique contributions of body diagram scores and psychosocial factors to pain intensity and disability in patients with musculoskeletal pain. J Orthop Sports Phys Ther 2017;47:88–96.

25. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–266.

26. Campbell MJ, Swinscow TDV. Statistics at Square One, ed 11. London: Wiley-Blackwell, 2009.

27. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD state-ment for reporting studies of diagnostic accuracy: Explanation and elaboration. Ann Intern Med 2003;138:W1–W12.

28. Häggman-Henrikson B, Bechara C, Pishdari B, Visscher CM, Ekberg E. Impact of catastrophizing in patients with temporo-mandibular disorders-a systematic review. J Oral Facial Pain Headache 2020;34:379–397.

29. Roelofs J, van Breukelen G, Sluiter J, et al. Norming of the Tampa Scale for Kinesiophobia across pain diagnoses and various countries. Pain 2011;152:1090–1095.

30. Plesh O, Adams SH, Gansky SA. Temporomandibular joint and muscle disorder-type pain and comorbid pains in a national US sample. J Orofac Pain 2011;25:190–198.

31. Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. Pain 1988;32:173–183.

32. Macfarlane GJ. The epidemiology of chronic pain. Pain 2016;157:2158–2159.

33. Häggman-Henrikson B, Visscher C, Wänman A, Ljótsson B, Peck C, Lövgren A. Even mild catastrophic thinking is related to pain intensity in individuals with painful temporomandibular disorders. J Oral Rehabil 2021;48:1193–1200.

34. Rollman A, Visscher CM, Gorter RC, Naeije M. Care seeking for orofacial pain. J Orofacial Pain 2012;26:206–214.

35. Poluha RL, De la Torre Canales G, Bonjardim LR, Conti PCR. Clinical variables associated with the presence of articular pain in patients with temporomandibular joint clicking. Clin Oral Investig 2021;25:3633–3640.